Matthew Boyd's most recent trade in enGene Holdings Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| enGene Holdings Inc | Matthew Boyd | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |